Reassessing withholding of statins during Paxlovid therapy: Is it worth risking loss of the pleiotropic effects of statins and cardiovascular protection?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reassessing withholding of statins during Paxlovid therapy: Is it worth risking loss of the pleiotropic effects of statins and cardiovascular protection?

Published:2023-06-08 Issue:18 Volume:80 Page:1204-1205
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Ariel Hannah¹,Ricupero Amy²,Cooke John P³

Affiliation:

1. Department of Chemistry and Biochemistry Queens College Forest Hills, NY , USA

2. Department of Pharmacy Practice Massachusetts College of Pharmacy and Health Sciences Boston, MA , USA

3. Cardiovascular Medicine Houston Methodist Medical Center Houston, TX , USA

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

https://academic.oup.com/ajhp/advance-article-pdf/doi/10.1093/ajhp/zxad135/50632281/zxad135.pdf

Reference10 articles.

1. Principles and practice of HIV-protease inhibitor pharmacoenhancement;Moyle;HIV Med,2001

2. Recommendations for the management of drug-drug interactions between the COVID-19 antiviral nirmatrelvir/ritonavir (Paxlovid) and comedications;Marzolini;Clin Pharmacol Ther,2022

3. HMG-CoA reductase inhibitors (statins),2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP